Skip to main content
13 April 2021
Last updated:
Tuesday 13 April 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Galapagos shows that the fittest can survive

    Friday 8 November 2019
    Interviewee/Contributor
    Piet Wigerinck and Walid Abi-Saab
    Organisation
    Galapagos NV
    Drug discovery
    Strategy
    • Read more about Galapagos shows that the fittest can survive
  • Risk sharing with Pharma -- is this the way to go?

    Tuesday 15 November 2011
    Interviewee/Contributor
    Onno van de Stolpe
    Organisation
    Galapagos NV
    Strategy
    Pharma
    Drug discovery
    • Read more about Risk sharing with Pharma -- is this the way to go?
  • How Galapagos built a business from discovery

    Tuesday 10 February 2009
    Interviewee/Contributor
    Onno van de Stolpe
    Organisation
    Galapagos NV
    Strategy
    Drug discovery
    • Read more about How Galapagos built a business from discovery
  • How Galapagos built a business from discovery

    Sunday 8 February 2009
    Interviewee/Contributor
    Onno van de Stolpe
    Organisation
    Galapagos NV
    Target discovery
    Rheumatoid arthritis
    Osteoarthritis
    Adenoviris
    • Read more about How Galapagos built a business from discovery

Organisations

  • Novo Nordisk Foundation
  • Affimed Therapeutics AG
  • Shire Plc
  • Themis Bioscience GmbH
  • Purespring Therapeutics Ltd
  • iTeos Therapeutics SA
  • Novasecta Ltd
  • NEO New Oncology AG
  • Nanobiotix SA
  • Evonetix Ltd

Interviewees and Contributers

  • William Sellers
  • Alastair Smith
  • Bruce Booth
  • Michael Nowak
  • Andrea van Elsas
  • Montserrat Vendrell
  • Michael Dawson
  • Eric Castaldi
  • Renée Aguiar-Lucander
  • Alex Gee

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

René Hoet becomes CSO at Montis Biosciences
Wednesday March 31 2021
Pan Cancer T makes board appointments
Wednesday March 31 2021
Björn Englund appointed CEO at Opterion
Wednesday March 31 2021
Sven Zimmermann joins Inotrem
Wednesday March 31 2021
New director at Mission Therapeutics
Wednesday March 31 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.